Galantamine Hydrobromide
Who holds supplier records for Galantamine Hydrobromide? 11 organisations hold a current record for Galantamine Hydrobromide: an active US FDA Type II Drug Master File or a CEP. A further 6 organisations have only historical (inactive) DMF filings. 8 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (3), Austria (2), Taiwan (1), Netherlands (1) and 4 other countries (4).
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Galantamine Hydrobromide: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/galantamine-hydrobromide
Reading the evidence
- 11 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- 5 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (11)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Galantamine Hydrobromide. Country is the organisation's recorded country, not necessarily the manufacturing site.
- APITORIA PHARMA PRIVATE LTDIndiaCEP Company GMP cert on recordActive DMF 21934 · latest filing Sept 2008
- JUBILANT BIOSYS LTDIndiaCEPActive DMF 21989 · latest filing Nov 2008
- SCINOPHARM TAIWAN LTDTaiwanCEPActive DMF 17863 · latest filing Dec 2004
- Dr. Reddy's Laboratories Ltd.India Company GMP cert on recordActive DMF 18013 · latest filing Jan 2005
- SANOCHEMIA PHARMAZEUTIKA AGAustriaActive DMF 26643 · latest filing Nov 2012
- TAPI NL BVNetherlandsActive DMF 18112 · latest filing Feb 2005
- ItalyCEP Company GMP cert on record
- Janssen Pharmaceutica NVBelgiumCEP Company GMP cert on recordInactive DMF 15384, 14425 · latest filing May 2001
- TAPI Czech Industries s.r.oCzech RepublicCEP Company GMP cert on record
- GALEN-N EOOD SofiaBulgariaCEPValid CEP holder (EDQM); not necessarily the manufacturer
- SANOCHEMIA PHARMAZEUTIKA GMBHAustriaCEPValid CEP holder (EDQM); not necessarily the manufacturer
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (8)
Certificates of Suitability on the EDQM register for Galantamine Hydrobromide, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 11 certificates in total, including withdrawn, expired, suspended and repeat certificates.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| GALEN-N EOOD Sofia | BG | CEP 2024-450 - Rev 01 Galantamine hydrobromide, Isolated from natural sources | Nov 2026 | — |
| SANOCHEMIA PHARMAZEUTIKA GMBH Neufeld An Der Leitha | AT | CEP 2023-389 - Rev 01 Galantamine hydrobromide, Produced by a synthetic process | Sept 2026 | Inspected Feb 2025 Austria |
| JUBILANT BIOSYS LIMITED Mysuru | IN | CEP 2011-123 - Rev 03 Galantamine hydrobromide, Produced by a synthetic process | Jan 2026 | — |
| TAPI CZECH INDUSTRIES S.R.O. Opava | CZ | CEP 2011-053 - Rev 03 Galantamine hydrobromide, Isolated from natural sources | Jan 2025 | Inspected Oct 2024 Czechia |
| APITORIA PHARMA PRIVATE LIMITED Hyderabad | IN | CEP 2009-316 - Rev 03 Galantamine hydrobromide, Produced by a synthetic process | Oct 2024 | — |
| SCINOPHARM TAIWAN LTD. Shan-Hua | TW | CEP 2011-011 - Rev 02 Galantamine hydrobromide, Produced by a synthetic process | Oct 2024 | — |
| JANSSEN PHARMACEUTICA NV Beerse | BE | R1-CEP 2012-248 - Rev 01 Galantamine hydrobromide, Produced by a synthetic process | Nov 2021 | — |
| INDENA S.P.A. Milano | IT | R1-CEP 2011-288 - Rev 01 Galantamine hydrobromide, Isolated from natural sources | Nov 2020 | — |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
Historical records (6)
Organisations whose Type II DMFs for Galantamine Hydrobromide are no longer active. These show a past filing, not current supply.
Show all 6 historical records
- HANDE PHARMA DEVELOPMENT LTDInactive DMF 21088 · filed Nov 2007
- JIANGSU SUNNY HEALTH INDUSTRY CO LTDInactive DMF 19134 · filed Jan 2006
- Belgium · Inactive DMF 18045, 18152 · filed Mar 2005
- India · Inactive DMF 18114 · filed Feb 2005
- MACFARLAN SMITH LTDInactive DMF 18078 · filed Feb 2005
- WUHAN SHIJI PHARMACEUTICAL CO LTDInactive DMF 17967 · filed Jan 2005
Other forms of this substance
A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:
Overview
Galantamine Hydrobromide is an alkaloid used for the treatment of mild to moderate Alzheimer's disease and various memory impairments. It functions as a reversible competitive inhibitor of acetylcholinesterase, enhancing acetylcholine availability in the brain.
Chemical identity
- IUPAC name
- (1S,12S,14R)-9-methoxy-4-methyl-11-oxa-4-azatetracyclo[8.6.1.01,12.06,17]heptadeca-6(17),7,9,15-tetraen-14-ol;hydrobromide
- Canonical SMILES
- CN1CC[C@@]23C=C[C@@H](C[C@@H]2OC4=C(C=CC(=C34)C1)OC)O.Br
- InChIKey
- QORVDGQLPPAFRS-XPSHAMGMSA-N
- Synonyms
- Razadyne API, (-)-galantamine hydrobromide, galanthamine hydrobromide, jilkon hydrobromide, lycoremine hydrobromide, nivalin, nivaline, razadyne, reminyl, tamilin
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Cholinesterase Inhibitor
- Mechanism of action
- Cholinesterase Inhibitors
Therapeutic areas
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Galantamine Hydrobromide?
11 organisations hold an active US FDA Type II Drug Master File or a CEP for Galantamine Hydrobromide: APITORIA PHARMA PRIVATE LTD (India), JUBILANT BIOSYS LTD (India), SCINOPHARM TAIWAN LTD (Taiwan), Dr. Reddy's Laboratories Ltd. (India), SANOCHEMIA PHARMAZEUTIKA AG (Austria), TAPI NL BV (Netherlands), INDENA SPA (Italy) and Janssen Pharmaceutica NV (Belgium), and 3 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Galantamine Hydrobromide Drug Master Files are active?
APITORIA PHARMA PRIVATE LTD (DMF 21934), JUBILANT BIOSYS LTD (DMF 21989), SCINOPHARM TAIWAN LTD (DMF 17863), Dr. Reddy's Laboratories Ltd. (DMF 18013), SANOCHEMIA PHARMAZEUTIKA AG (DMF 26643) and TAPI NL BV (DMF 18112). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Galantamine Hydrobromide records mean?
6 organisations have only inactive Type II DMFs for Galantamine Hydrobromide. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does Galantamine Hydrobromide have a European Certificate of Suitability?
Yes. 8 organisations hold a valid CEP for Galantamine Hydrobromide on the EDQM register, including GALEN-N EOOD Sofia (BG), SANOCHEMIA PHARMAZEUTIKA GMBH Neufeld An Der Leitha (AT), JUBILANT BIOSYS LIMITED Mysuru (IN), TAPI CZECH INDUSTRIES S.R.O. Opava (CZ), APITORIA PHARMA PRIVATE LIMITED Hyderabad (IN) and SCINOPHARM TAIWAN LTD. Shan-Hua (TW) and 2 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
How do I qualify a Galantamine Hydrobromide supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Galantamine Hydrobromide?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.